BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 12646477)

  • 1. Recurrent pleomorphic adenoma of the parotid gland in pediatric and adult patients: value of multiple lesions as a diagnostic indicator.
    Koral K; Sayre J; Bhuta S; Abemayor E; Lufkin R
    AJR Am J Roentgenol; 2003 Apr; 180(4):1171-4. PubMed ID: 12646477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pleomorphic parotid adenomas and their recurrence].
    Federspil PA; Federspil P; Schätzle W
    HNO; 1994 Jan; 42(1):28-35. PubMed ID: 8150670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pleomorphic adenoma of the parotid gland. Results of surgical treatment].
    Huber A; Schmid S; Fisch U
    HNO; 1994 Sep; 42(9):553-8. PubMed ID: 7989227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-report: metastasizing pleomorphic adenoma of the parotid gland.
    van der Schroeff MP; de Ru JA; Slootweg PJ
    B-ENT; 2007; 3(1):21-5. PubMed ID: 17451122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cancerous recurrence of a pleomorphic adenoma of the parotid. Comments on a case].
    Lavorgna G; Savastano G; Rubino C
    Minerva Stomatol; 1992 Apr; 41(4):145-50. PubMed ID: 1334224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent pleomorphic adenoma of the parotid gland.
    Leonetti JP; Marzo SJ; Petruzzelli GJ; Herr B
    Otolaryngol Head Neck Surg; 2005 Sep; 133(3):319-22. PubMed ID: 16143173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple primary pleomorphic adenomas of the unilateral parotid gland].
    Helmstaedter V; Beutner D; Drebber U; Huttenbrink KB; Streppel M
    Laryngorhinootologie; 2007 Jun; 86(6):448-50. PubMed ID: 17219338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
    Glas AS; Hollema H; Nap RE; Plukker JT
    Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The recurrent multifocal pleomorphic adenoma].
    Vigili MG; Sciarretta F; Marzetti A; Marzetti F
    Acta Otorhinolaryngol Ital; 1993; 13(1):31-42. PubMed ID: 8135096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour recurrence after surgical removal of parotid pleomorphic salivary adenoma using a retrograde facial nerve dissection technique.
    O'Regan B; Bharadwaj G
    Br J Oral Maxillofac Surg; 2012 Jul; 50(5):417-9. PubMed ID: 21880405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between histopathology of pleomorphic adenoma in the parotid gland and recurrence after superficial parotidectomy.
    Park GC; Cho KJ; Kang J; Roh JL; Choi SH; Kim SY; Nam SY
    J Surg Oncol; 2012 Dec; 106(8):942-6. PubMed ID: 22740329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients.
    Wittekindt C; Streubel K; Arnold G; Stennert E; Guntinas-Lichius O
    Head Neck; 2007 Sep; 29(9):822-8. PubMed ID: 17563905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrences of pleomorphic adenomas of the parotid: changing attitudes].
    Paris J; Facon F; Chrestian MA; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):229-34. PubMed ID: 15038565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent benign tumors of the parotid gland and their tendency for becoming malignant].
    Mann W; Beck C; Karatay MC
    Laryngol Rhinol Otol (Stuttg); 1985 Mar; 64(3):133-5. PubMed ID: 2985894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and management of recurrent parotid pleomorphic adenoma.
    Witt RL; Eisele DW; Morton RP; Nicolai P; Poorten VV; Zbären P
    Laryngoscope; 2015 Apr; 125(4):888-93. PubMed ID: 25289881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of metastasizing myoepithelial carcinoma of the parotid gland arising in a recurrent pleomorphic adenoma.
    Ohba S; Fujimori M; Ito S; Matsumoto F; Hata M; Takayanagi H; Wada R; Ikeda K
    Auris Nasus Larynx; 2009 Feb; 36(1):123-6. PubMed ID: 18650039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma).
    Emodi O; El-Naaj IA; Gordin A; Akrish S; Peled M
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2092-8. PubMed ID: 20728030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrograde parotidectomy for pleomorphic adenoma of the parotid gland: a conservative and effective approach.
    Scarpini M; Amore Bonapasta S; Ruperto M; Vestri A; Bononi M; Caporale A
    J Craniofac Surg; 2009 May; 20(3):967-9. PubMed ID: 19461345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent pleomorphic adenoma: results of surgical treatment.
    Makeieff M; Pelliccia P; Letois F; Mercier G; Arnaud S; César C; Garrel R; Crampette L; Guerrier B
    Ann Surg Oncol; 2010 Dec; 17(12):3308-13. PubMed ID: 20645014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-histopathological review of 255 patients who underwent parotidectomy for pleomorphic adenoma: a 10-year retrospective study-a proposal for an optimal diagnostic and therapeutic algorithm for patients with recurrent pleomorphic adenoma.
    Zoccali F; Cialente F; Colizza A; Ralli M; Greco A; de Vincentiis M
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3329-3335. PubMed ID: 36872347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.